Received Jun 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUA4 | INFLUENZA (SEASONAL) (FLUAD QUADRIVALENT) | SEQIRUS, INC. | UNK | No batch number | — |
dripping of or from nose; This spontaneous case, initially received on 11-May-2024 and 14-May-2024 (being processed together), was reported by a non health professional and concerns an elderly male patient. The patient's medical history was not reported. The patient's concomitant medications included rosuvastatin and losartan. The patient's historical vaccines included plenty of flu vaccines (brand not specified) received on an unknown date for unknown indication, after which the patient has never had this situation. Administration of company suspect drug(s): On 31-Dec-2023, the patient received Fluad Quadrivalent, Indication, Route of administration, Dose, Anatomical location, Lot number: Not reported. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, an unknown amount of time after vaccination, the patient experienced dripping of or from the nose (outcome: not recovered/not resolved). The patient reported there was no decrease in dripping of or from the nose. In a day mostly 3-to-9 time, dripping starts without any reason and sometimes the patient has to keep tissue in that nostril or sometimes both. The patient reported the dripping from the nose became more frequent, up to six times a day. At the time of initial reporting, the patient had not recovered from the event of 'Runny nose'. Non-drug treatment/Other action taken: Fluad Quadrivalent action taken: Not Applicable Reporters assessment: The reporter did not provide a causality assessment and considered the event as non-serious.; Reporter's Comments: Due to lack of information and unclear temporal relationship, causality for the event of 'dripping of or from the nose' is assessed as unassessable.
Comments: None
Rosuvastatin; Losartan